This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Critical Illness
and you are
over 18
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

Remifentanil is one kind of opiates with strong analgesic effect,which has the rapid onset and short lasting duration. Remifentanil usually is used to help reducing the pain of patients with mechanical ventilation in ICU. Maybe it can also be used to ease the pain in ICU small short time operation.The purpose of this study is to determine (1) whether remifentanil is effective in small short time operations in ICU or not, (2) the save range of remifentanil in small short time operations in ICU, (3) and the adverse reaction that happens in these operations.

Provided treatments

  • Drug: Remifentanil
  • Drug: Lidocaine
  • Drug: Remifentanil+Lidocaine
  • Drug: Midazolam

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02635802. The sponsor of the trial is The First Affiliated Hospital of Zhengzhou University and it is looking for 1500 volunteers for the current phase.
Official trial title:
the Research of Analgesia and Sedation Effect of Remifentanil on ICU Short Operation